“…Furthermore, despite impressive advances such as organoid models and patient‐derived xenografts, these preclinical systems, especially small‐animal preclinical systems (where the vast majority of preclinical FLASH research is being performed), can still only offer a limited recapitulation of a human patient. Specifically, in the context of radiobiological preclinical studies, radiation responses are highly dependent on the choice and source of cell lines, the choice of animal species and often the specific animal strain within the species, and the immune status of the animal model 44,45 . We believe therefore, that we are now at a point where additional exploratory preclinical research is going to be inefficient (in our opponents’ own estimate, it will take “a generation”!)…”